NEWS
12.06.11
Quest Diagnostics Launches Simplexa™ Dengue Test in Brazil, First Commercial Molecular Test Approved for Nation’s Public and Private Health Testing
The Simplexa™ Dengue molecular test kit developed Focus Diagnostics has been registered for distribution in Brazil. The test kit is the first commercial real-time polymerase chain reaction (RT-PCR) test to be approved for use by Brazil’s public and private health laboratories for testing for Dengue viruses.
11.15.11
Quest Diagnostics CE Marks Simplexa™ Test for Cytomegalovirus for Sale in Europe
With the new Focus Diagnostics' Simplexa molecular test on the 3M™ Integrated Cycler, the company now offers one of the most comprehensive molecular transplant-testing menus in Europe
11.01.11
Quest Diagnostics Announces Launch of Simplexa™ Direct Test for Influenza and
Respiratory Viruses in Europe
Respiratory Viruses in Europe
Focus Diagnostics product eliminates nucleic-acid sample extraction with proprietary technology, for faster testing
06.09.11
Quest Diagnostics Wins Gold Medical Design Excellence Award (MDEA) for Diagnostic Innovation
Focus Diagnostics Simplexa™ molecular test on the 3M™ Integrated Cycler wins highest MDEA Award for in vitro diagnostics
05.05.11
Quest Diagnostics Launches Simplexa™ C. Difficile Universal Direct Test in Europe
First test from the Focus Diagnostics' Simplexa product line for the hospital-acquired infection (HAI) market
04.06.11Quest Diagnostics Honored for Diagnostic Innovation
at 2011 Edison Awards
Simplexa™ molecular diagnostic test on the 3M™ Integrated Cycler
wins bronze for best new product, science and medical diagnostic
New York City, NY
05.24.10
Simplexa™ molecular RT-PCR test runs on the 3M Integrated Cycler
10.16.09
FDA Issues Another Emergency Use Authorization for Commercial H1N1 Flu Test to Quest Diagnostics’ Focus Diagnostics
Test runs on the 3M Integrated Cycler; Reflects first Simplexa™ branded molecular test kits from Focus Diagnostics
